TH
Theratechnologies
TH·NASDAQMontreal CAFounded 1993150 employees
Micro CapbiotechPublicInfectious Disease
Platform: HIV Tesamorelin
Market Cap
$0.06B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (TH)
Loading TH stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Ribozanubrutinib | TH-8683 | Phase 2/3 | 2 | FXIa | HCC | ||
| Daratenlimab | TH-7509 | Phase 1 | 2 | EZH2 | CKD |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)